The US Food and Drug Administration’s drug safety recommendations and long-acting beta2-agonist dispensing pattern changes in adult asthma patients: 2003–2012

por Zhou, Esther H, Seymour, Sally, Goulding, Margie R, Kang, Elizabeth M, Major, Jacqueline M, Iyasu, Solomon
Publicado 2017

The Effect of FDA Drug Safety Communications on Patterns of Tiotropium Dispensing: A U.S. Health Plan Claims Database Study

por Major, Jacqueline M., Zhou, Esther H., Ding, Yulan, Ly, Thomas, Li, Jie, Pinheiro, Simone P., Seymour, Sally
Publicado 2018

Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis

por Sinha, Michael S, Freifeld, Clark C, Brownstein, John S, Donneyong, Macarius M, Rausch, Paula, Lappin, Brian M, Zhou, Esther H, Dal Pan, Gerald J, Pawar, Ajinkya M, Hwang, Thomas J, Avorn, Jerry, Kesselheim, Aaron S
Publicado 2018